1. Home
  2. AKRO vs TEX Comparison

AKRO vs TEX Comparison

Compare AKRO & TEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKRO
  • TEX
  • Stock Information
  • Founded
  • AKRO 2017
  • TEX 1933
  • Country
  • AKRO United States
  • TEX United States
  • Employees
  • AKRO N/A
  • TEX N/A
  • Industry
  • AKRO Biotechnology: Pharmaceutical Preparations
  • TEX Construction/Ag Equipment/Trucks
  • Sector
  • AKRO Health Care
  • TEX Industrials
  • Exchange
  • AKRO Nasdaq
  • TEX Nasdaq
  • Market Cap
  • AKRO 3.7B
  • TEX 3.3B
  • IPO Year
  • AKRO 2019
  • TEX N/A
  • Fundamental
  • Price
  • AKRO $54.00
  • TEX $55.98
  • Analyst Decision
  • AKRO Buy
  • TEX Buy
  • Analyst Count
  • AKRO 10
  • TEX 10
  • Target Price
  • AKRO $73.56
  • TEX $56.20
  • AVG Volume (30 Days)
  • AKRO 4.1M
  • TEX 685.7K
  • Earning Date
  • AKRO 11-07-2025
  • TEX 10-30-2025
  • Dividend Yield
  • AKRO N/A
  • TEX 1.19%
  • EPS Growth
  • AKRO N/A
  • TEX N/A
  • EPS
  • AKRO N/A
  • TEX 2.67
  • Revenue
  • AKRO N/A
  • TEX $5,169,000,000.00
  • Revenue This Year
  • AKRO N/A
  • TEX $7.37
  • Revenue Next Year
  • AKRO N/A
  • TEX $3.92
  • P/E Ratio
  • AKRO N/A
  • TEX $21.36
  • Revenue Growth
  • AKRO N/A
  • TEX N/A
  • 52 Week Low
  • AKRO $21.34
  • TEX $31.53
  • 52 Week High
  • AKRO $58.40
  • TEX $58.66
  • Technical
  • Relative Strength Index (RSI)
  • AKRO 68.71
  • TEX 60.07
  • Support Level
  • AKRO $53.40
  • TEX $52.85
  • Resistance Level
  • AKRO $54.05
  • TEX $58.66
  • Average True Range (ATR)
  • AKRO 0.26
  • TEX 1.95
  • MACD
  • AKRO -0.03
  • TEX 0.35
  • Stochastic Oscillator
  • AKRO 72.46
  • TEX 82.86

About AKRO Akero Therapeutics Inc.

Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.

About TEX Terex Corporation

Terex Corp is a manufacturer of materials processing machinery, waste and recycling solutions, mobile elevating work platforms (MEWPs), and equipment for the electric utility industry. The company designs builds, and supports products used in maintenance, manufacturing, energy, waste and recycling, minerals and materials management, construction, and the entertainment industry. The products are manufactured in North America, Europe, and Asia Pacific and sold all over the world. The company reports business in the following segments: (i) Materials Processing, (ii) Aerial Work Platforms, and (iii) Environmental Solutions Group.

Share on Social Networks: